1. | karmakid17 | |
2. | roseannhogan | |
3. | mpee3438 | |
4. | pharmaseise |
1. | karmakid17 | |
2. | roseannhogan | |
3. | mpee3438 | |
4. | pharmaseise |
1. | pharmaseise 05/17/2018 Agree that data from today will keep this stock rising |
2. | roseannhogan 01/23/2018 Stock Offering News |
3. | karmakid17 02/28/2018 Gene Therapy Holds Out Hope for Diabetics |
4. | mpee3438 01/23/2018 Waking up from a nap to see this, great |
5. | mpee3438 05/17/2018 Audentes Announces Continuing Positive Data from First Dose Cohort of ASPIRO, a Phase 1/2 Clinical Trial of AT132 in Patients With X-Linked Myotubular Myopathy |
6. | roseannhogan 02/06/2018 Audentes Therapeutics Announces Selection of Optimized Clinical Development Candidate for Pompe Disease Program |
7. | karmakid17 03/29/2018 Filed $150 mln mixed securities shelf offering |
8. | karmakid17 01/23/2018 Yep :( |
9. | karmakid17 01/26/2018 prices 5.75M share offering at $35 |
10. | roseannhogan 05/17/2018 Happy |